查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935699

合成生物學自動化平台市場：按組件、技術、應用和最終用戶分類，全球預測（2026-2032年）

Synthetic Biology Automation Platform Market by Component, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，合成生物學自動化平台市場價值將達到 61.7 億美元，到 2026 年將成長至 64.3 億美元，到 2032 年將達到 88.7 億美元，複合年成長率為 5.32%。

關鍵市場統計數據
基準年 2025 61.7億美元
預計年份：2026年 64.3億美元
預測年份 2032 88.7億美元
複合年成長率 (%) 5.32%

這是一本策略性入門指南，說明了整合自動化平台如何重塑合成生物學實驗的實驗室通量、可重複性和決策。

合成生物學自動化平台處於實驗室實踐、計算分析和工業規模生物製造的關鍵交匯點。本文概述了該技術的範圍、整合的複雜性以及推動其在研究和商業環境中應用的實際需求。文章全面闡述了儀器、軟體和實驗室工作流程的進步如何說明，從而實現新型的可重複性、高通量和數據驅動型生物學。

模組化系統、嵌入式人工智慧和跨學科融合是改變合成生物學平台的關鍵技術和營運轉折點。

合成生物學自動化領域正經歷一系列變革性轉變，其影響遠超過儀器設備的漸進式改進。其中最顯著的轉變包括：將先進的計算層整合到實驗室硬體中、實現模組化和互操作系統的標準化，以及基於數據驅動的實驗設計重新定義工作流程。這些因素共同作用，正在重塑價值鏈：物理自動化逐漸成為一種通用技術，而軟體和分析技術則成為差異化的關鍵。

對近期美國關稅政策變化將如何影響合成生物學自動化生態系統的供應鏈、採購決策和營運策略進行定性評估

美國新關稅和貿易政策調整的推出可能會對合成生物學自動化生態系統產生累積影響，具體體現在供應鏈重組、成本分配和合規負擔等。關稅往往會增加國際採購硬體零件的到岸成本，促使採購團隊重新評估供應商多元化和前置作業時間緩衝。對於需要特殊製造的設備和耗材，關稅可能會獎勵企業將生產外包或進行垂直整合，以尋求對關鍵上游投入的控制。

詳細的細分分析解釋了組件、技術、應用和最終用戶方面的差異如何驅動差異化產品策略和採用趨勢。

要充分了解合成生物學自動化領域的機會和風險，對市場區隔的正確理解至關重要。根據其組成要素，該市場可分為硬體、服務和軟體三大類：硬體提供實現物理實驗所需的設備和耗材；服務提供系統整合、培訓和實驗室營運管理；軟體則提供將濕實驗流程與數位化洞察相結合的編配、資料管理和分析功能。

區域趨勢和政策主導解釋了美洲、歐洲/中東/非洲和亞太地區不同的採用模式和採購行為。

區域趨勢將對合成生物學自動化平台的普及速度和模式產生重大影響。在美洲，密集的研究和私營部門的投資共同推動了整合自動化解決方案的快速普及，製藥和工業生物技術公司對規模化和合規性的重視尤為突出。北美實驗室傾向於採用模組化系統，並強調軟體驅動的編配和能夠簡化檢驗和部署的服務夥伴關係。

企業原型和策略行為揭示了合成生物學自動化領域製造商、軟體供應商、整合商和服務供應商之間的競爭、合作和價值創造。

要了解合成生物學自動化生態系統中的企業行為，需要專注於其策略定位、產品系列和夥伴關係方式。主要參與者大致可分為幾類：儀器製造商，強調可靠性和吞吐量；軟體和分析提供商，專注於資料互通性和實驗自動化；整合商和系統供應商，提供承包實驗室自動化和工作流程編配；以及以服務為導向的機構，提供合約研究、實驗室管理和客製化自動化實施方案。

產業領導者應採取切實可行的策略行動和營運重點，以降低自動化採用的風險並加快實現價值的時間。

產業領導者可以採取實際行動，加速合成生物學自動化平台的普及應用，降低風險，並創造價值。首先，應優先考慮硬體和軟體元件之間的模組化互通性，以保持柔軟性並避免供應商鎖定。這種方法可以縮短整合前置作業時間，並支援迭代式工作流程改進。其次，應投資於人才培養，將技術培訓和流程設計專業知識結合，使實驗室團隊能夠在保持科學嚴謹性的同時，最大限度地提高自動化帶來的生產力優勢。

一項嚴謹的混合方法調查方法，結合了從業人員訪談、實驗室檢驗、技術基準測試以及供應鏈和政策分析，得出了基於證據的結論。

本分析的調查方法結合了定性和定量調查、與關鍵相關人員的直接對話以及嚴謹的二手資料研究。主要資料來源包括對實驗室經理、採購人員、自動化工程師和技術主管的深入訪談，以獲取有關實施挑戰、整合模式和供應商關係的第一手資訊。現場考察和實驗室參觀則用於觀察工作流程配置，檢驗有關吞吐量、人體工學設計和系統互通性的說法。

一份概述組織在實施合成生物學自動化平台時應關注的策略要務和實際優先事項的摘要

總之，合成生物學自動化平台正在改變科學研究實驗室和工業界設計、執行和擴展實驗的方式。計算智慧、精準編輯工具、高通量儀器和靈活的流體處理技術的融合，正在實現生產力和可重複性的新高度。儘管政策變革和貿易措施帶來了複雜性，但目前的趨勢是傾向於模組化、以數據為中心且以穩健的服務模式為基礎的系統。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 合成生物學自動化平台市場（依組件分類）

  • 硬體
  • 服務
  • 軟體

9. 合成生物學自動化平台市場（依技術分類）

  • 人工智慧和機器學習
    • 資料探勘
    • 影像分析
    • 預測建模
  • 基於 CRISPR 的平台
    • 基礎編輯系統
    • 基因編輯工具
  • 高通量定序
    • 次世代定序
    • 第三代定序
  • 微流體技術
    • 連續流微流體技術
    • 數位微流體技術
    • 液滴微流體技術
  • 機器人自動化
    • 桌上型機器人
    • 高通量自動化系統
    • 移動機器人

10. 合成生物學自動化平台市場（依應用領域分類）

  • 農業生物技術
  • 診斷
  • 工業生物加工
  • 治療藥物生產

第11章 合成生物學自動化平台市場（依最終用戶分類）

  • 學術研究機構
  • 合約研究機構
  • 政府研究機構
  • 工業生物技術公司
  • 製藥和生物技術公司

12. 各地區合成生物學自動化平台市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

13. 合成生物學自動化平台市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國合成生物學自動化平台市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國合成生物學自動化平台市場

16. 中國合成生物學自動化平台市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Asimov, Inc.
  • Autodesk, Inc.
  • Codex DNA, Inc.
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Integrated DNA Technologies, Inc.
  • LabGenius Ltd.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN NV
  • Synthace Ltd.
  • Synthego Corporation
Product Code: MRR-9A6A6F2974BA

The Synthetic Biology Automation Platform Market was valued at USD 6.17 billion in 2025 and is projected to grow to USD 6.43 billion in 2026, with a CAGR of 5.32%, reaching USD 8.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.17 billion
Estimated Year [2026] USD 6.43 billion
Forecast Year [2032] USD 8.87 billion
CAGR (%) 5.32%

A strategic primer detailing how integrated automation platforms are reshaping laboratory throughput, reproducibility, and decision-making across synthetic biology operations

Synthetic biology automation platforms are at a pivotal intersection of laboratory practice, computational analytics, and industrial-scale biomanufacturing. This introduction frames the breadth of technologies, the complexity of integration, and the practical imperatives driving adoption across research and commercial environments. It synthesizes how advances in instrumentation, software, and laboratory workflows are converging to enable reproducibility, throughput, and a new mode of data-driven biology.

As laboratories confront the dual pressures of accelerating discovery and controlling operational complexity, automation platforms are emerging as the connective tissue that harmonizes wet-lab processes with digital infrastructure. The introduction outlines the principal value propositions-reduced manual variability, accelerated experiment cycles, and enhanced traceability-while setting expectations for the subsequent sections, which examine technological inflections, policy-related headwinds, segmentation nuances, regional dynamics, corporate behavior, and practical recommendations for strategic leaders.

Key technological and operational inflection points showing how modular systems, embedded AI, and cross-disciplinary integrations are transforming synthetic biology platforms

The synthetic biology automation landscape is evolving through a set of transformative shifts that extend well beyond incremental improvements in instrumentation. The most notable transitions are the embedding of advanced computational layers into laboratory hardware, the normalization of modular and interoperable systems, and the redefinition of workflows around data-centric experiment design. Together these forces are altering the value chain: software and analytics increasingly determine differentiation even as physical automation becomes commoditized.

Moreover, cross-disciplinary convergence is facilitating novel use cases. Artificial intelligence and machine learning are moving from pilot projects to embedded orchestration, enabling closed-loop experimentation that shortens hypothesis-to-validation cycles. Parallel advances in microfluidics and high-throughput sequencing are driving a redistribution of experimental scale, allowing smaller labs to access capabilities once limited to centralized facilities. Consequently, collaboration models are shifting: partnerships between instrument OEMs, software developers, and end users are becoming the primary route to deliver integrated solutions rather than single-vendor propositions.

Qualitative assessment of how recent United States tariff shifts may reshape supply chains, procurement decisions, and operational strategies across synthetic biology automation ecosystems

The introduction of new tariff measures and trade policy adjustments in the United States can exert a meaningful cumulative effect on synthetic biology automation ecosystems, manifesting through supply chain reconfiguration, cost allocation, and compliance burden. Tariffs tend to increase landed costs for hardware components sourced internationally, prompting procurement teams to reassess supplier diversification and lead-time buffers. For instruments and consumables that require specialized manufacturing, tariffs can create incentives for nearshoring production or for vertical integration by companies seeking to control critical upstream inputs.

Operationally, increased import duties and trade friction expand the administrative overhead associated with international procurement. Companies respond by refining product classifications, optimizing bill-of-materials sourcing, and negotiating longer-term supply agreements to stabilize pricing. From a technology perspective, software and cloud-delivered capabilities are less directly affected by customs duties, but they can be impacted by ancillary effects such as reduced hardware deployments or changes in capital expenditure cycles. In addition, tariffs influence partnership strategies: vendors and end users may prioritize local alliances, contract research organizations, or domestic manufacturing capacity to mitigate exposure. Ultimately, the cumulative effects are most visible in procurement patterns, capital allocation priorities, and regional supply chain design rather than in immediate shifts to scientific practice.

An in-depth segmentation synthesis explaining how component, technology, application, and end-user distinctions drive differentiated product strategies and adoption dynamics

A precise understanding of segmentation is essential to navigate opportunity and risk within the synthetic biology automation domain. Based on component, the market differentiates among hardware, services, and software, with hardware encompassing instruments and consumables that enable physical experimentation, services covering system integration, training, and managed laboratory operations, and software providing orchestration, data management, and analytics that tie wet-lab processes to digital insights.

Based on technology, the landscape spans artificial intelligence and machine learning, CRISPR-based platforms, high-throughput sequencing, microfluidics, and robotic automation. Within artificial intelligence and machine learning, capabilities such as data mining, image analysis, and predictive modeling are extending the reach of automated experimentation. CRISPR-based platforms further segment into base editing systems and gene editing tools that vary by precision and application scope. High-throughput sequencing differentiates between next-generation sequencing and third-generation sequencing approaches that offer distinct trade-offs in read length and throughput. Microfluidics is expressed through continuous flow microfluidics, digital microfluidics, and droplet microfluidics, each enabling different scales and modalities of fluid handling. Robotic automation ranges from bench-top robots to high-throughput automation systems and mobile robotics that support flexible laboratory layouts.

Based on application, commercial and research priorities divide across agricultural biotechnology, diagnostics, industrial bioprocessing, and therapeutics production, with each application shaping requirements for throughput, regulatory compliance, and integration. Based on end user, adoption spans academic research institutions, contract research organizations, government research laboratories, industrial biotechnology firms, and pharmaceutical and biotechnology companies, reflecting diverse procurement cycles, validation needs, and tolerance for experimental risk. Together, these segmentation perspectives provide a multidimensional framework for assessing technology fit, go-to-market models, and investment priorities.

Regional dynamics and policy-driven variations that explain divergent adoption patterns and procurement behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics materially influence the pace and pattern of adoption for synthetic biology automation platforms. In the Americas, research intensity and private-sector investment combine to foster rapid uptake of integrated automation solutions, with strong demand from pharmaceutical companies and industrial biotechnology firms that prioritize scale and regulatory compliance. North American laboratories often favor modular systems with emphasis on software-driven orchestration and service partnerships that streamline validation and deployment.

In Europe, Middle East & Africa, heterogeneous regulatory frameworks and public-sector research initiatives shape adoption trajectories. Several European countries are advancing national strategies to support bioeconomy innovation, which encourages collaboration between academic institutions and industrial partners. Procurement practices in this region tend to emphasize interoperability, open standards, and long-term service agreements. In the Asia-Pacific region, a mix of aggressive public investment, manufacturing capacity, and rapidly expanding biotech sectors is accelerating both hardware production and in-country deployment. Governments are investing in local capability building, which combined with strong industrial demand, is encouraging localization of supply chains and the rise of regional integrators. Across regions, differences in funding models, regulatory requirements, and industrial priorities dictate distinct go-to-market tactics for vendors and service providers.

Corporate archetypes and strategic behaviors that reveal how manufacturers, software vendors, integrators, and service providers compete, collaborate, and create value in the synthetic biology automation space

Understanding corporate behavior within the synthetic biology automation ecosystem requires attention to strategic positioning, product portfolios, and partnership approaches. Key players generally fall into a few distinct archetypes: instrument manufacturers that emphasize reliability and throughput; software and analytics providers that focus on data interoperability and experiment automation; integrators and systems providers who deliver turnkey laboratory automation and workflow orchestration; and service-centric organizations that offer contract research, managed lab services, and customized automation deployments.

Strategically, companies are differentiating through vertical integration, open-platform strategies, and alliance formation. Some firms prioritize proprietary hardware-software synergy to lock in workflows and deliver predictable results, while others adopt an open-architecture approach to attract a broader ecosystem of application developers and equipment vendors. Collaboration with academic labs, CROs, and industrial partners remains a central route to validation and early adoption. In addition, corporate investment in after-sales support, training, and remote diagnostics is proving decisive for customer retention and expansion. Leadership teams that balance product innovation with practical deployment expertise tend to achieve deeper penetration into regulated and industrial applications.

Actionable strategic moves and operational priorities that industry leaders should implement to de-risk adoption and accelerate value capture from automation investments

Industry leaders can take concrete actions to accelerate adoption, reduce risk, and capture value from synthetic biology automation platforms. First, prioritize modular interoperability across hardware and software components to preserve flexibility and avoid vendor lock-in; this approach reduces integration lead time and supports iterative workflow refinement. Second, invest in workforce capability building that pairs technical training with process design expertise, enabling lab teams to extract the full productivity gains of automation while maintaining scientific rigor.

Third, develop procurement strategies that incorporate supplier diversity, total cost of ownership assessments, and scenario planning for trade policy shifts. Fourth, emphasize data governance frameworks that ensure provenance, auditability, and secure data flows between instruments and analytics stacks. Fifth, cultivate strategic alliances that combine domain expertise, systems integration, and commercial channels; these partnerships accelerate time to value for customers. Finally, pilot closed-loop experimentation projects that pair AI-driven decisioning with automated execution, using them as demonstrators to build internal capability and to validate ROI through operational metrics rather than theoretical projections.

A rigorous mixed-methods research approach combining practitioner interviews, laboratory validation, technical benchmarking, and supply chain and policy analysis to ensure evidence-based conclusions

The research methodology underpinning this analysis combined qualitative and quantitative inquiry, primary stakeholder engagement, and rigorous secondary research. Primary inputs included in-depth interviews with laboratory managers, procurement leads, automation engineers, and technology executives to capture firsthand perspectives on deployment challenges, integration patterns, and vendor relationships. Site visits and laboratory walkthroughs were used to observe workflow configurations and to validate claims about throughput, ergonomics, and system interoperability.

Secondary work encompassed a comprehensive review of scientific literature, patent filings, vendor technical documentation, and regulatory guidance to map technology capabilities and compliance considerations. Comparative product benchmarking and architectural assessments were conducted to evaluate interoperability, scalability, and support models. Finally, supply chain and policy analyses were performed to understand sourcing dependencies and the implications of trade measures. Together, these methods produced a balanced assessment that privileges practitioner experience and technical realities over promotional narratives.

A closing synthesis that articulates the strategic imperatives and practical priorities for organizations adopting synthetic biology automation platforms

In conclusion, synthetic biology automation platforms are reshaping how experiments are designed, executed, and scaled across research and industry. The convergence of computational intelligence, precision editing tools, high-throughput instrumentation, and flexible fluidic handling is enabling a new tier of productivity and reproducibility. While policy shifts and trade measures introduce complexity, the dominant trajectory favors systems that are modular, data-centric, and supported by robust service models.

Decision-makers should view automation as a strategic capability that extends beyond cost reduction to encompass accelerated innovation cycles, improved quality control, and new commercialization pathways. By aligning procurement, workforce development, and partnership strategies with technical realities, organizations can both mitigate risks associated with supply chain and trade uncertainty and unlock sustained operational advantage. The coming period will reward actors who integrate technical foresight with pragmatic execution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Synthetic Biology Automation Platform Market, by Component

  • 8.1. Hardware
  • 8.2. Services
  • 8.3. Software

9. Synthetic Biology Automation Platform Market, by Technology

  • 9.1. Artificial Intelligence And Machine Learning
    • 9.1.1. Data Mining
    • 9.1.2. Image Analysis
    • 9.1.3. Predictive Modeling
  • 9.2. Crispr-Based Platforms
    • 9.2.1. Base Editing Systems
    • 9.2.2. Gene Editing Tools
  • 9.3. High-Throughput Sequencing
    • 9.3.1. Next-Generation Sequencing
    • 9.3.2. Third-Generation Sequencing
  • 9.4. Microfluidics
    • 9.4.1. Continuous Flow Microfluidics
    • 9.4.2. Digital Microfluidics
    • 9.4.3. Droplet Microfluidics
  • 9.5. Robotic Automation
    • 9.5.1. Bench-Top Robots
    • 9.5.2. High-Throughput Automation Systems
    • 9.5.3. Mobile Robotics

10. Synthetic Biology Automation Platform Market, by Application

  • 10.1. Agricultural Biotechnology
  • 10.2. Diagnostics
  • 10.3. Industrial Bioprocessing
  • 10.4. Therapeutics Production

11. Synthetic Biology Automation Platform Market, by End User

  • 11.1. Academic Research Institutions
  • 11.2. Contract Research Organizations
  • 11.3. Government Research Laboratories
  • 11.4. Industrial Biotechnology Firms
  • 11.5. Pharmaceutical And Biotechnology Companies

12. Synthetic Biology Automation Platform Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Synthetic Biology Automation Platform Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Synthetic Biology Automation Platform Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Synthetic Biology Automation Platform Market

16. China Synthetic Biology Automation Platform Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Amyris, Inc.
  • 17.7. Asimov, Inc.
  • 17.8. Autodesk, Inc.
  • 17.9. Codex DNA, Inc.
  • 17.10. GenScript Biotech Corporation
  • 17.11. Ginkgo Bioworks, Inc.
  • 17.12. Integrated DNA Technologies, Inc.
  • 17.13. LabGenius Ltd.
  • 17.14. Merck KGaA
  • 17.15. Novozymes A/S
  • 17.16. QIAGEN N.V.
  • 17.17. Synthace Ltd.
  • 17.18. Synthego Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DATA MINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DATA MINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DATA MINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY IMAGE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY IMAGE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY IMAGE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PREDICTIVE MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PREDICTIVE MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BASE EDITING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BASE EDITING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BASE EDITING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GENE EDITING TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GENE EDITING TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GENE EDITING TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTINUOUS FLOW MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTINUOUS FLOW MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTINUOUS FLOW MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIGITAL MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIGITAL MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIGITAL MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DROPLET MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DROPLET MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DROPLET MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BENCH-TOP ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BENCH-TOP ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BENCH-TOP ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT AUTOMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT AUTOMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT AUTOMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MOBILE ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MOBILE ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MOBILE ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOPROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOPROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOPROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THERAPEUTICS PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THERAPEUTICS PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THERAPEUTICS PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 225. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 235. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 237. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)